The Effect of Contrast Media on Erythrocytes in Healthy Volunteers

This study has been completed.
Sponsor:
Collaborator:
GE Healthcare
Information provided by:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00285506
First received: January 31, 2006
Last updated: May 25, 2006
Last verified: January 2006
  Purpose

The purpose of the study is to test the effect that contrast media (dye) has on cellular integrity (structure)


Condition
Healthy Volunteers

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: The Effect of Low-Osmolar and Iso-Osmolar Contrast Media on Erythrocytes in Healthy Volunteers.

Further study details as provided by Medical University of South Carolina:

Estimated Enrollment: 20
Study Start Date: January 2006
Estimated Study Completion Date: January 2006
Detailed Description:

The influence of several radiological contrast media on erythrocyte morphology and function has been investigated in the past (1). However, published data is sparse and does not include the assessment of iso-osmolar agents as compared to low-osmolar agents.

In addition, the effect of the injection of contrast media at higher temperatures (i.e. > room or body temperature), which may be beneficial for the rapid injection of more viscous contrast media at multi detector-row CT angiography, has never been evaluated.

We intend to assess the hypothesis, that iso-osmolar contrast media (i.e. Visipaque) exerts less effect on erythrocyte morphology and function as compared to low-osmolar agents.

In addition, we intend to identify the upper temperature limit, at which contrast media can be injected, without affecting erythrocyte integrity.

Subjects will have up tp 400 mLs (approximately 26 tablespoons) of blood drawn. The blood will be kept at body temperature in a petri dish or similar container and exposed to contrast media (dye).

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Subjects must be at least 18 years old
  • Subjects must be at least 110lbs and

Exclusion Criteria:

  • Subjects may not be pregnant
  • Subjects must not possess any medical conditions that would preclude them from participating
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00285506

Locations
United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425
Sponsors and Collaborators
Medical University of South Carolina
GE Healthcare
Investigators
Principal Investigator: U. Joseph Schoepf, MD Medical University of South Carolina
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00285506     History of Changes
Other Study ID Numbers: HR 15813
Study First Received: January 31, 2006
Last Updated: May 25, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by Medical University of South Carolina:
Healthy Volunteers

Additional relevant MeSH terms:
Contrast Media
Diagnostic Uses of Chemicals
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 18, 2014